{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T06:22:08Z","timestamp":1788070928038,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.preghy.2021.06.012","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:34:42Z","timestamp":1625142882000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium"],"prefix":"10.1016","volume":"25","author":[{"given":"Ana","family":"Dubon Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Devlieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Redekop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katleen","family":"Vandeweyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Verlohren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liona C.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2021.06.012_b0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/GCO.0b013e32835e0ef5","article-title":"Hypertensive disease of pregnancy and maternal mortality","volume":"25","author":"Lo","year":"2013","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.06.012_b0010","doi-asserted-by":"crossref","unstructured":"H. Stepan, S. Kuse-Fohl, W. Klockenbusch, et al. Diagnosis and treatment of hypertensive pregnancy disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015\/018, December 2013). Geburtshilfe Frauenheilkd. 75 (2015) 900\u2013914. https:\/\/doi.org\/10.1055\/s-0035-1557924.","DOI":"10.1055\/s-0035-1557924"},{"issue":"2","key":"10.1016\/j.preghy.2021.06.012_b0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens."},{"issue":"3","key":"10.1016\/j.preghy.2021.06.012_b0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin. Perinatol."},{"issue":"8","key":"10.1016\/j.preghy.2021.06.012_b0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/00325481.2018.1527169","article-title":"Preterm and term preeclampsia: differences in biochemical parameter and pregnancy outcomes","volume":"130","author":"Chandra","year":"2018","journal-title":"Postgrad. Med."},{"issue":"3","key":"10.1016\/j.preghy.2021.06.012_b0030","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mob.2000.104224","article-title":"Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation","volume":"182","author":"Witlin","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2021.06.012_b0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.preghy.2015.02.002","article-title":"Pre-eclampsia causes adverse maternal outcomes across the gestational spectrum","volume":"5","author":"Pettit","year":"2015","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2021.06.012_b0040","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/bmj.323.7323.1213","article-title":"Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study","volume":"323","author":"Irgens","year":"2001","journal-title":"BMJ."},{"issue":"3","key":"10.1016\/j.preghy.2021.06.012_b0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/uog.5252","article-title":"Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age","volume":"31","author":"Yu","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.preghy.2021.06.012_b0050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/14767050903258746","article-title":"Evidence for distinct preterm and term phenotypes of preeclampsia","volume":"23","author":"Phillips","year":"2010","journal-title":"J. Matern. Fetal Neonatal. Med."},{"key":"10.1016\/j.preghy.2021.06.012_b0055","doi-asserted-by":"crossref","unstructured":"Publications Committee Society for Maternal-Fetal Medicine, B.M. Sibai. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am. J. Obstet. Gynecol. 205 (2011) 191\u2013198. https:\/\/doi.org\/10.1016\/j.ajog.2011.07.017.","DOI":"10.1016\/j.ajog.2011.07.017"},{"issue":"9","key":"10.1016\/j.preghy.2021.06.012_b0060","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/aogs.13173","article-title":"Early gestational age at preeclampsia onset is associated with subclinical atherosclerosis 12 years after delivery","volume":"96","author":"Christensen","year":"2017","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"3","key":"10.1016\/j.preghy.2021.06.012_b0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn. Ther."},{"issue":"7","key":"10.1016\/j.preghy.2021.06.012_b0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2021.06.012_b0075","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"10","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.preghy.2021.06.012_b0080","doi-asserted-by":"crossref","unstructured":"W. Gyselaers, P. Jonckheer, N. Ahmadzai, et al. What are the recommended clinical assessment and screening tests during pregnancy? \u2013 Appendix. https:\/\/kce.fgov.be\/en\/what-are-the-recommended-clinical-assessment-and-screening-tests-during-pregnancy, 2015 (accessed 14 January 2021).","DOI":"10.57598\/R248S"},{"issue":"Suppl 1","key":"10.1016\/j.preghy.2021.06.012_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.preghy.2021.06.012_b0090","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2021.06.012_b0095","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/uog.17399","article-title":"Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks' gestation","volume":"49","author":"O'Gorman","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2021.06.012_b0100","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks' gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O'Gorman","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2021.06.012_b0105","doi-asserted-by":"crossref","first-page":"199.e1","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2021.06.012_b0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn. Ther."},{"issue":"1","key":"10.1016\/j.preghy.2021.06.012_b0115","doi-asserted-by":"crossref","first-page":"126.e1","DOI":"10.1016\/j.ajog.2017.10.024","article-title":"First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume","volume":"218","author":"Sonek","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2021.06.012_b0120","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000477934","article-title":"First-trimester combined multimarker prospective study for the detection of pregnancies at a high risk of developing preeclampsia using the Fetal Medicine Foundation-algorithm","volume":"43","author":"Guizani","year":"2018","journal-title":"Fetal Diagn. Ther."},{"issue":"6","key":"10.1016\/j.preghy.2021.06.012_b0125","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2021.06.012_b0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2021.06.012_b0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/uog.19076","article-title":"Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia","volume":"53","author":"Ortved","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"7491","key":"10.1016\/j.preghy.2021.06.012_b0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ."},{"issue":"2","key":"10.1016\/j.preghy.2021.06.012_b0145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.06.012_b0150","unstructured":"World Health Organization, WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. https:\/\/www.who.int\/reproductivehealth\/publications\/maternal_perinatal_health\/9789241548335\/en\/, 2011 (accessed 14 January 2021)."},{"issue":"1","key":"10.1016\/j.preghy.2021.06.012_b0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ajog.2018.03.018","article-title":"Optimal aspirin dosing for preeclampsia prevention","volume":"219","author":"Seidler","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.preghy.2021.06.012_b0160","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jogc.2017.04.040","article-title":"Low rates of aspirin use for the prevention of preeclampsia","volume":"39","author":"Viguiliouk","year":"2017","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2021.06.012_b0165","unstructured":"T. Firoz, J. Sotsuna, O. Adetoro. Treatment postpartum \u2013 immediate and long term, in: L. Magee, P. von Dadelszen, W. Stones, M. Mathai, (Eds.) The FIGO textbook of pregnancy hypertension. The Global Library of Women\u2019s Medicine, 2016."},{"key":"10.1016\/j.preghy.2021.06.012_b0170","unstructured":"Statbel, Number of births per day. https:\/\/statbel.fgov.be\/en\/open-data\/number-births-day, 2018 (accessed 15 January 2021)."},{"key":"10.1016\/j.preghy.2021.06.012_b0175","unstructured":"Vzw Studiecentrum voor Perinatale Epidemiologie (SPE), Perinatal activities Flanders. https:\/\/www.zorg-en-gezondheid.be\/sites\/default\/files\/atoms\/files\/EMBARGO_SPE_Perinatale%20activiteiten%20in%20Vlaanderen%202018.pdf, 2018 (accessed 14 January 2021)."},{"key":"10.1016\/j.preghy.2021.06.012_b0180","unstructured":"C. Leroy, N. Moreau, V. Van Leeuw. Sant\u00e9 p\u00e9rinatale en Wallonie \u2013 Ann\u00e9e 2018. https:\/\/www.cepip.be\/pdf\/rapport_CEPIP_Wal2018_2tma.pdf, 2018 (accessed 14 January 2021)."},{"key":"10.1016\/j.preghy.2021.06.012_b0185","unstructured":"I. Cleemput, M. Neyt, S. Van de Sande, N. Thiry, Belgian guidelines for economic evaluations and budget impact analyses: second edition (KCE Report 183C). https:\/\/kce.fgov.be\/en\/belgian-guidelines-for-economic-evaluations-and-budget-impact-analyses-second-edition, 2012 (accessed 14 January 2021)."},{"key":"10.1016\/j.preghy.2021.06.012_b0190","unstructured":"RIZIV, NomenSoft. https:\/\/ondpanon.riziv.fgov.be\/Nomen\/nl\/search, 2019. (accessed 23 October 2019)."},{"key":"10.1016\/j.preghy.2021.06.012_b0195","unstructured":"Statbel, Consumer price index, by base year, COICOP nomenclature, by year and month. https:\/\/bestat.statbel.fgov.be\/bestat\/crosstable.xhtml?datasource=a956f4c1-ac3b-4f95-b7bb-a37e705f6446, 2019. (accessed 10 April 2020)."},{"key":"10.1016\/j.preghy.2021.06.012_b0200","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/AOG.0000000000001115","article-title":"A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States","volume":"126","author":"Werner","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2021.06.012_b0205","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","article-title":"Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women","volume":"72","author":"Mone","year":"2018","journal-title":"Hypertension."},{"key":"10.1016\/j.preghy.2021.06.012_b0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"134","author":"Mallampati","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2021.06.012_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2675101","article-title":"Evidence-based prevention of preeclampsia: commonly asked questions in clinical practice","volume":"2019","author":"Wertaschnigg","year":"2019","journal-title":"J. Pregnancy."},{"issue":"7","key":"10.1016\/j.preghy.2021.06.012_b0220","doi-asserted-by":"crossref","first-page":"e022056","DOI":"10.1136\/bmjopen-2018-022056","article-title":"Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial","volume":"8","author":"Mone","year":"2018","journal-title":"BMJ Open."},{"key":"10.1016\/j.preghy.2021.06.012_b0225","doi-asserted-by":"crossref","unstructured":"G.P. Guy, K. Leslie, D. Diaz Gomez, et al. Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study, BJOG. 128 (2) (2021) 149\u2013156. https:\/\/doi.org\/10.1111\/1471-0528.16361.","DOI":"10.1111\/1471-0528.16361"},{"key":"10.1016\/j.preghy.2021.06.012_b0230","doi-asserted-by":"crossref","unstructured":"B. Sibai, G. Dekker, M. Kupferminc, Pre-eclampsia, Lancet. 365 (2005) 785\u2013799. https:\/\/doi.org\/10.1016\/S0140-6736(05)17987-2.","DOI":"10.1016\/S0140-6736(05)17987-2"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921000738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778921000738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:56:49Z","timestamp":1761897409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778921000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":46,"alternative-id":["S2210778921000738"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2021.06.012","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2021.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}]}}